REPL
Replimune Group, Inc.NASDAQStock$8.88+0.26 (+2.96%)Mkt Cap 732.8MP/E —Div Yield —Beta 0.91Vol 1.6MAvg Vol 7.8M
52W$1.70
$12.63
ETFs That Hold REPL (Replimune Group, Inc.)
1M
+70.11%
3M
+20.65%
6M
-7.60%
YTD
-0.22%
1Y
-9.66%
3Y
-63.03%
5Y
-74.30%
ETFs That Hold REPL
Replimune Group, Inc. is held by 49 ETFs. The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| JKL | iShares Morningstar Small-Cap Value ETF | 0.01% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.00% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.00% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.06% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.23% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.01% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.01% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| PWS | Pacer WealthShield ETF | 0.04% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
| NIFE | Direxion Fallen Knives ETF | 0.52% |
| IWMW | iShares Russell 2000 BuyWrite ETF | 0.02% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.02% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
Excludes leveraged and inverse ETFs.
Frequently Asked Questions
How many ETFs hold REPL?
Replimune Group, Inc. (REPL) is held by 49 ETFs (excluding leveraged and inverse funds). The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).
What is the largest ETF that holds REPL?
By fund size, XBI (State Street SPDR S&P Biotech ETF) with $8.11B in AUM holds 0.26% of its portfolio in REPL, representing $21.4M in market value.
What percentage of CNCR is REPL?
REPL makes up 3.54% of CNCR (Loncar Cancer Immunotherapy ETF), making it one of the largest positions in that fund.
Is REPL in the S&P 500?
REPL is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.